Weight loss-related findings: Individuals using GLP-1s for 18 months show the same pattern of reduced medical cost growth, reductions in hospitalizations due to MACE and lower claims incidence for a range of conditions
In fact, clinical weight loss trials with tirzepatide monotherapy show 2022% body weight reduction over 68 weeksresults that rival or exceed most multi-agent protocols reported in the literature
The hippocampus is particularly vulnerable to TBI, as evidenced in part by immediate mechanically induced damage to interneurons in the dentate granule cell layer of the hippocampus that are remote from the site of insult (Gallyas and Zoltay, 1992
According to the Center for Disease Control, more than 2 in 5 U.S
Alfonso-Prieto M, Vidossich P, Rodriguez-Fortea A, Carpena X, Fita I, Loewen P, Rovira C (2008)
Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L